testing guidelines

News

Genetic Testing Underutilized in Women With History of Ovarian Cancer

08/22/2017

JCP Editors

Less than 20% of patients with a history of ovarian cancer meeting National Comprehensive Cancer Network (NCCN) guidelines have undergone genetic testing or have discussed testing with their health care...

Less...

08/22/2017

Journal of Clinical Pathways

Research in Review

Novel Ovarian Cancer Subtypes Associated With Survival Outcomes Following Surgery

08/02/2017

JCP Editors

High-grade serous ovarian cancer can be categorized in five molecular subtypes associated with survival and surgical outcomes, according to research published in Clinical Cancer Research (August...

...

08/02/2017

Journal of Clinical Pathways

Research in Review

Comparing Prognostic Values of MRI or PET-CT at Multiple Myeloma Diagnosis

07/12/2017

JCP Editors

Researchers identified which imaging technique is better for evaluating prognosis of newly-diagnosed multiple myeloma, published in the Journal of Clinical Oncology (published online July 7, 2017;...

...

07/12/2017

Journal of Clinical Pathways

Research in Review

Prostate Cancer Scanning Helps Detect Further Disease, Improve Care

06/28/2017

JCP Editors

Positron emission tomography (PET) and computed tomography (CT) scans specific to prostate cancer can detect further disease and improve clinical management, according to recent research. Ga68-Prostate Specific...

...

06/28/2017

Journal of Clinical Pathways

Research in Review

Underused Blood Test Helps Alter Treatment Strategy for Colon Cancer

06/26/2017

JCP Editors

A routinely available blood test can help improve risk stratification and guide additional therapy for stage II colon cancer. ----- Related Content Adjuvant Chemotherapy Improves Colon Cancer Outcomes Colon...

A...

06/26/2017

Journal of Clinical Pathways

Research in Review

Prostate Cancer Testing Guidelines Omit Critical Genetic Features

06/13/2017

JCP Editors

Current National Comprehensive Cancer Network (NCCN) guidelines and Gleason scores cannot reliably stratify patients with risk of prostate cancer for the presence or absence of pathogenic germline variants,...

...

06/13/2017

Journal of Clinical Pathways

Research in Review

Early PET Scan Improves Outcomes for Patients With Hodgkin Lymphoma

06/08/2017

JCP Editors

Response to positron emission tomography (PET) scan after two cycles of standard treatment allows for early treatment adaption for patients with early-stage Hodgkin lymphoma, according to research published in the...

...

06/08/2017

Journal of Clinical Pathways

Research in Review

Financial Burden for Patients With Early-Stage Breast Cancer After Surveillance Testing

05/31/2017

JCP Editors

Women who have been treated for early-stage breast cancer and receive surveillance testing are at risk of adverse events and increased financial burden, according to research that will be presented at the 2017 ASCO...

Women...

05/31/2017

Journal of Clinical Pathways

Research in Review

PARP-1 Measurement Guides Treatment Decisions in Ovarian Cancer

05/12/2017

JCP Editors

New research shows that blocking poly (ADP-ribose) polymerase-1 (PARP-1) may have a greater impact than restoring BRCA1 for the treatment of ovarian cancer, according to research presented at the 2017 American...

New...

05/12/2017

Journal of Clinical Pathways

Department

Researchers Offer Protocol for Cardiac Monitoring in Cancer Survivors

03/15/2017

JCP Editors

Researchers debuted guidelines for a two-tiered cardiac monitoring system aimed at identifying cancer survivors considered at high risk for cardiotoxic events. ----- Related Content Prostate Cancer Treatment...

...

03/15/2017

Journal of Clinical Pathways